Since chloramphenicol is an efficient broad spectrum antibiotic that is widely used, the possibility that it may be the cause of hematological disorders is, naturally, a serious one. Recently, five cases of fatal aplastic anemia have come to our attention. In each instance, we believe chloramphenicol to be etiologically implicated. It is our purpose to report these cases and to review the literature on hematological disorders believed to be caused by this drug.
REPORT OF CASES
A 31-year-old housewife had received phenobarbital and atropine intermittently for over a year because of nervousness. In December, 1951, an upper respiratory tract infection developed, and she was given a total of 15 capsules of chloramphenicol. Early in January, 1952, she received an additional six capsules. On this occasion, urticaria developed over the lower extremities and lasted for several days. No other recent history of exposure to drugs or toxic agents could
Rheingold JJ, Spurling CL. CHLORAMPHENICOL AND APLASTIC ANEMIA. JAMA. 1952;149(14):1301–1304. doi:10.1001/jama.1952.02930310037008
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: